Martin Jouza

Martin Jouza

Auto-generated profile, based on publicly available information

Martin Jouza

Faculty of Medicine, Masaryk University, Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in BMJ Paediatrics Open
Verified
Journal Article
Open access
PDF file
ASAndrea Stanikova
Andrea Stanikova
MJMartin Jouza
Martin Jouza
JBJúlia Bohošová
Júlia Bohošová
Ondrej SlabyOndrej Slaby
Ondrej Slaby
PJPetr Jabandziev
Petr Jabandziev
Although necrotising enterocolitis (NEC) is a serious, life-threatening disease, improved neonatal care is increasing the number of survivors with NEC among extremely preterm neonates. Therapy is nevertheless mostly symptomatic and the mortality rate remains high, especially among neonates requiring surgery. Therefore, it is important to focus on preventing the disease and modifiable risk factors. NEC’s pathophysiology is multifaceted, with key factors being immaturity of the immune and barrier protective mechanisms of the premature gut and exaggerated proinflammatory reaction to insults like gut hypoxia, enteral nutrition or microbial dysbiosis. The role of the intestinal microbiome in the pathophysiology of NEC has been a subject of research for many years, but to date no specific pathogen or type of dysbiosis has been connected with NEC development. This review assesses current knowledge as to the role of the intestinal microbiota in the pathophysiology of NEC and the possibilities for positively influencing it